BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer

posted on Feb 05, 2019 05:28PM

BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer

https://www.ncbi.nlm.nih.gov/pubmed/30715616

Mentions ZEN-3694 but does not cover in depth.

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply